SYLPAXXO
"SYLPAXXO" is a word mark owned by Novartis AG, filed at IP Australia on August 17, 2026. It is waiting to be published and covers class 5 (Pharmaceuticals).
- Status
- Awaiting publication
- Since September 24, 2026
- Filed
- August 17, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 2687294
- Registration no.
- Not yet
- Office
- IP Australia
- IP Australia
- Mark type
- Word mark
- 1 class
Who owns SYLPAXXO
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Novartis AG
NOVN · Basel, Switzerland
Representative
Davies Collison Cave Pty Ltd
Davies Collison Cave Pty Ltd
What the mark covers
The products and services SYLPAXXO is filed for, grouped by Nice class.
pharmaceutical preparations
What has happened so far
Steps recorded by IP Australia, newest first.
- Early Acceptance Notice correspondence sent
- Awaiting examination
- Application Received
About SYLPAXXO
Who owns the trademark "SYLPAXXO"?
IP Australia trademark "SYLPAXXO" (application 2687294) is owned by Novartis AG.
What is the status of "SYLPAXXO"?
Its status at IP Australia is: awaiting publication.
Get this data via the API
Everything on this page comes from the Signa API. Pull SYLPAXXO and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a01194-8e6c-718a-9075-13961eeb877f
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a01194-8e6c-718a-9075-13961eeb877f",
"object": "trademark",
"mark_text": "SYLPAXXO",
"status": {
"primary": "pending",
"stage": "pending_publication"
},
"office_code": "AU",
"application_number": "2687294",
"filing_date": "2026-08-17",
"nice_classes": [
5
],
"owners": [
{
"name": "Novartis AG",
"entity_id": "ent_019ee98e-3962-72d9-8871-bdf198255e1a"
}
]
}